March 05, 2018
Safety Analysis of Leishmania Vaccine Used in a Randomized Canine Vaccine/Immunotherapy Trial
In Leishmania infantum–endemic countries, controlling infection within dogs, the domestic reservoir, is critical to public health. There is a need for safe vaccines that prevent canine progression with disease and transmission to others. Protective vaccination against Leishmania requires mounting a strong, inflammatory, Type 1 response. Three commercially available canine vaccines on the global veterinary market use saponin or inflammatory antigen components (Letifend) as a strong pro-inflammatory adjuvant. There is very little information detailing safety of saponin as an adjuvant in field trials. Safety analyses for the use of vaccine as an immunotherapeutic in asymptomatically infected animals are completely lacking. Leishmania infantum, the causative agent of canine leishmaniasis, is enzootic within U.S. hunting hounds. We assessed the safety of LeishTec® after use in dogs from two different clinical states: 1) without clinical signs and tested negative on polymerase chain reaction and serology or 2) without clinical signs and positive for at least one Leishmania diagnostic test. Vaccine safety was assessed after all three vaccinations to quantify the number and severity of adverse events. Vaccinated animals had an adverse event rate of 3.09%, whereas placebo animals had 0.68%. Receiving vaccine was correlated with the occurrence of mild, site-specific, reactions. Occurrence of severe adverse events was not associated with having received vaccine. Infected, asymptomatic animals did not have a higher rate of adverse events. Use of vaccination is, therefore, likely to be safe in infected, asymptomatic animals.
Read the full article in The American of Tropical Medicine and Hygiene.
More from CNAS
-
Defense Tech’s Big Test
Commentary
Introduction The U.S. defense sector is at the front end of the largest private capital cycle it has ever seen, with venture capital investment assuming an inceasingly powerfu...
By Mela Louise Norman
-
U.S. Missile Stockpiles Under Pressure
Video
Germany is buying US Tomahawk missiles even as Europe races to build its own defense industry. Bloomberg Economics' Becca Wasser, an adjunct senior fellow at the Center for a ...
By Becca Wasser
-
Trump Uses Air Force One to Depart Turkey
Video
Becca Wasser, an adjunct senior fellow at the Center for a New American Security, joins CNN This Morning to discuss why President Trump flew home from Turkey on the old the Ai...
By Becca Wasser
-
Why the U.S. Is Losing the Drone War
Podcast
The US defense industry is struggling to keep up with the revolution in cheap drones vs. expensive reusable military equipment. Today on the show, we talk with Stacie Pettyjoh...
By Stacie Pettyjohn
